Prevalence of pharmacogenomic variants in 100 pharmacogenes among Southeast Asian populations under the collaboration of the Southeast Asian Pharmacogenomics Research Network (SEAPharm)

• Main Authors: Runcharoen, Chakkaphan, Fukunaga, Koya, Sensorn, Insee, Iemwimangsa, Nareenart, Klumsathian, Sommon, Tong, Hang, Vo, Nam Sy, Le, Ly, Hlaing, Tin Maung, Thant, Myo, Mohd Zain, Shamsul, Mohamed, Zahurin, Pung, Yuh-Fen, Capule, Francis, Nevado, Jose, Silao, Catherine Lynn, Al-Mahayri, Zeina N., Ali, Bassam R., Yuliwulandari, Rika, Prayuni, Kinasih, Zahroh, Hilyatuz, Noor, Dzul Azri Mohamed, Xangsayarath, Phonepadith, Xayavong, Dalouny, Kounnavong, Sengchanh, Sayasone, Somphou, Kordou, Zoe, Liopetas, Ioannis, Tsikrika, Athina, Tsermpini, Evangelia-Eirini, Koromina, Maria, Mitropoulou, Christina, Patrinos, George P., Kesornsit, Aumpika, Charoenyingwattana, Angkana, Wattanapokayakit, Sukanya, Mahasirimongkol, Surakameth, Mushiroda, Taisei, Chantratita, Wasun
• Format: Article
• Published: Springernature 2021
• Subjects: BF Psychology; QH426 Genetics
• Online Access: http://eprints.um.edu.my/35066/

Pharmacogenomics can enhance the outcome of treatment by adopting pharmacogenomic testing to maximize drug efficacy and lower the risk of serious adverse events. Next-generation sequencing (NGS) is a cost-effective technology for genotyping several pharmacogenomic loci at once, thereby increasing pu...